Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Billich
Andreas Billich, Vienna AT
| Patent application number | Description | Published |
|---|---|---|
| 20110021530 | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS - Methods of treating an SCD-mediated skin disorder or condition in a mammal, preferably a human, including administering to a mammal in need thereof a compound of formula (I): where x, y, W, V, R | 01-27-2011 |
Andreas Billich, Wien AT
| Patent application number | Description | Published |
|---|---|---|
| 20090156588 | 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES - The present invention relates 3,4-dihydro-benzo[e][1,3]oxazin-2-ones which are substituted at the nitrogen atom by unsubstituted or substituted (C | 06-18-2009 |
| 20100022482 | aSMase inhibitors - The present invention relates to compounds of formula | 01-28-2010 |
| 20100029007 | Biomarker in Inflammatory Diseases - The use of CD1B, or CD1D, respectively as a target for a disorder selected from Systemic Lupus Erythematosus (SLE), Lupus Anticoagulant (LA) Rheumatoid Arthritis (RA) and Idiopathic Thrombocytopenic Purpura; and the use of CD1D as a target in a disorder which is Multiple Sclerosis (MS), e.g. as a biomarker; a method for preparing a diagnostic kit and a method for identifying agents that modulates a disorder which is mediated by elevated levels of CD1B, or CD1D, respectively, in case of CD1B, or CD1D, respectively selected from Systemic Lupus Erythematosus (SLE), Lupus Anticqagulant (LA) Rheumatoid Arthritis (RA) and Idiopathic Thrombocytopenic Purpura; and in case of CD1D a disorder which is Multiple Sclerosis (MS). | 02-04-2010 |
Andreas Billich, Modling AT
| Patent application number | Description | Published |
|---|---|---|
| 20080318255 | Fluorescent Labeled Sphingosines - The present invention relates to a method (assay) for determining the activity of an enzyme selected from the group consisting of a sphingosine kinase and a phosphatase involved in the sphingolipid pathway by use of a labeled sphingosine. | 12-25-2008 |
Andreas Billich, Wien DE
| Patent application number | Description | Published |
|---|---|---|
| 20080306058 | Combinations Comprising a Vegf Receptor Inhibitor - A composition comprising a VEGF receptor inhibitor and a penetration enhancer and uses thereof. | 12-11-2008 |
Jürgen Billich, Aurich DE
| Patent application number | Description | Published |
|---|---|---|
| 20090188410 | Dynamic seating device - The present invention relates to a dynamic seating device with a seat plate ( | 07-30-2009 |
Jürgen Billich, Aurich DE
| Patent application number | Description | Published |
|---|---|---|
| 20090188410 | Dynamic seating device - The present invention relates to a dynamic seating device with a seat plate ( | 07-30-2009 |